BrightGene Bio-Medical Technology Co. Ltd.SSE: 688166

Indicative Announcement on ""Brightgene Convertible Bonds"" Expected to Meet Conditions for Redemption

· Issued by BrightGene Bio-Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

BrightGene Bio-Medical Technology Co. Ltd. has issued an indicative announcement regarding its convertible bonds, stating they are expected to meet redemption conditions. The announcement outlines the terms of redemption for the bonds and the circumstances under which the company may choose to redeem them. It also includes a risk warning for investors to understand the implications of the redemption terms and to stay informed about future announcements.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Indicative Announcement on ""Brightgene Convertible Bonds"" Expected to Meet Conditions for Redemption

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

BrightGene Bio-Medical Technology Co. Ltd. on 6ix

Earlier from BrightGene Bio-Medical Technology

Later from BrightGene Bio-Medical Technology

All BrightGene Bio-Medical Technology news releases